Crain's Chicago Business2h
Maia Bio touts two advances for its lead cancer drug in development
THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...
The American Journal of Managed Care1d
Dr Toon Van Gorp: Mirvetuximab Soravtansine Should Be Global Standard for FRα+ Ovarian Cancer
Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...
Amity students develop ‘Mukta’ to detect oral cancer
A group of BTech students from Amity University, Lucknow, has developed an AI-based device named 'Mukta' that can detect oral ...
Fierce Pharma1d
AstraZeneca offers early look at Datroway-Tagrisso combo in EGFR lung cancer as phase 3 trial rolls on
As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...
Indian-Made Gene Therapy For Blood Cancer Shows 73% Response Rate In Clinical Trials
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...